Trial Profile
Phase 2a study of PB1046 in patients with cardiomyopathy.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 19 Mar 2015
Price :
$35
*
At a glance
- Drugs Pemziviptadil (Primary)
- Indications Cardiomyopathies
- Focus Therapeutic Use
- 19 Mar 2015 New trial record